Design, molecular Docking, synthesis and evaluation of xanthoxylin hybrids as dual inhibitors of IL-6 and acetylcholinesterase for Alzheimer's disease-Reference-Cited by-同舟云学术

Design, molecular Docking, synthesis and evaluation of xanthoxylin hybrids as dual inhibitors of IL-6 and acetylcholinesterase for Alzheimer's disease

Published:2022-04 Issue: Volume:121 Page:105670
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Kaur Sukhvir,Bansal Yogita

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference29 articles.

1. A review on Alzheimer's disease pathophysiology and its management: an update;Kumar;Pharmacol. Rep.,2015

2. U.S. Food and Drug Administration, Aducanumab (marketed as Aduhelm) information. https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-drug, 2021 (accessed on 4th October 2021).

3. Cyclooxygenase-1 in human Alzheimer and control brain: Quantitative analysis of expression by microglia and CA3 hippocampal neurons;Yermakova;J. Neuropatho. Exp. Neur.,1999

4. The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: Implications for translational research;Choi;Trends Pharmacol. Sci.,2009

5. Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer’s disease;Meena;Bioorg. Med. Chem.,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromone hybrids as interleukin-6 and acetylcholinesterase inhibitor for treatment of Alzheimer's disease: Design, docking, synthesis and evaluation;European Journal of Medicinal Chemistry Reports;2024-12

2. Dual-target inhibitors based on acetylcholinesterase: Novel agents for Alzheimer's disease;European Journal of Medicinal Chemistry;2024-12

3. Design of Multi-Target drugs of HDACs and other Anti-Alzheimer related Targets: Current strategies and future prospects in Alzheimer’s diseases therapy;Bioorganic Chemistry;2024-10

4. Exploring potential inhibitors of acetylcholinesterase, lactate dehydrogenases, and glutathione reductase from Hagenia abyssinica (Bruce) J.F. Gmel. based on multi-target ultrafiltration-liquid chromatography-mass spectrometry and molecular docking;Journal of Ethnopharmacology;2024-10

5. Current pharmacophore based approaches for the development of new anti-Alzheimer’s agents;Bioorganic & Medicinal Chemistry;2024-09